PRESS RELEASE published on 01/04/2024 at 14:00, 10 months 17 days ago Amdocs' Market Leadership in Key Domains Recognized by Top Telecom Industry Analysts Amdocs, a leading provider of software and services to communications and media companies, has been recognized as a global leader in monetization platforms, digital transformation, customer experience, cloud services, and network automation by top independent analyst firms. The recognition spans across various domains including leadership in monetization and revenue management, AI and customer experience, quality engineering, industry recognition, and network orchestration. This acknowledgment solidifies Amdocs' position as an industry leader and showcases their ongoing innovation which will be showcased at Mobile World Congress Barcelona, February 26-29, 2024. Amdocs Monetization Platforms Customer Experience Cloud Services Network Automation
PRESS RELEASE published on 12/21/2023 at 14:00, 11 months ago Amdocs Included in Dow Jones Sustainability Index (DJSI) for Fifth Consecutive Year
PRESS RELEASE published on 12/13/2023 at 22:30, 11 months 8 days ago Amdocs Limited Files Fiscal 2023 Annual Report
PRESS RELEASE published on 12/05/2023 at 14:00, 11 months 16 days ago Amdocs’ Vubiquity Technology and Services Support A+E Networks(R) as it Expands Video-On-Demand Entertainment Across Streaming Services and Pay TV Providers Amdocs' Vubiquity chosen by A+E Networks to manage VOD Transport & Content Distribution Services, expanding content reach and opening new monetization opportunities for SVOD and AVOD Amdocs Vubiquity A+E Networks VOD Content Distribution
PRESS RELEASE published on 11/28/2023 at 14:00, 11 months 23 days ago Amdocs Awarded 2023 AWS Partner Award
PRESS RELEASE published on 11/07/2023 at 22:20, 1 year ago Amdocs’ Vubiquity Selected by Lionsgate to Streamline Content Accessibility of 18,000-Plus Film and TV Catalog through Cutting-Edge Automation
PRESS RELEASE published on 11/07/2023 at 22:05, 1 year ago VodafoneZiggo Extends Multi-Year Managed Services Agreement with Amdocs to Elevate Operational Excellence
PRESS RELEASE published on 11/07/2023 at 07:00, 1 year ago Amdocs Limited Reports Fourth Quarter & Full Year Fiscal 2023 Results; Initiates Fiscal 2024 Outlook
PRESS RELEASE published on 10/24/2023 at 14:00, 1 year ago Amdocs Releases First Quarter Fiscal 2024 Investor Conference Schedule
PRESS RELEASE published on 10/19/2023 at 14:00, 1 year 1 month ago Bharti Airtel Collaborates with Amdocs to Accelerate Digital Transformation
Published on 11/22/2024 at 09:00, 3 hours 4 minutes ago Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 12 hours 4 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 13 hours 59 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 14 hours 14 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 15 hours 49 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/22/2024 at 11:54, 10 minutes ago PIERER Mobility denies media reports about Mark Mateschitz's participation in PIERER Mobility and KTM
Published on 11/22/2024 at 11:45, 19 minutes ago How 5G Transforms Life: A Foreigner's Journey Through East China's Digital Revolution
Published on 11/22/2024 at 11:21, 43 minutes ago Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy
Published on 11/22/2024 at 11:06, 58 minutes ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 06:58, 1 day 5 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 16 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 18 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 18 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 2 days 4 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo